An observational study performed among 303 participants with and without T2DM who underwent computed tomography (CT) angiography due to chest pain, reported a positive association of endogenous GLP-1 levels with coronary plaque burden ( In addition to direct actions in coronary arteries, GLP-1 RAs can prevent the formation and progression of coronary atherosclerosis through indirect mechanisms, such as maintaining glycemic control, losing weight, decreasing systolic blood pressure, obtaining beneficial effects from lipid levels, inhibiting platelet activation, reducing systemic inflammation and levels of circulating BNP ( Glucagon-Like Peptide 1 Receptor Agonists and Vasospasm of Epicardial Coronary Arteries Spasms in the smooth muscle layer of the coronary artery wall can be focal or diffuse, resulting in vasospastic angina or myocardial infarction (MI), respectively
Diabetes Obes Metab 15(6):503512
Considering the increase in GLP-1 and FGF19, which consequently leads to an increase in insulin induced by BA in patients with history of MBS, our aim was to see whether the time interval until the diagnosis of PBH was shorter in patients who had undergone cholecystectomy
Synthetic incretin receptor agonists are similar to natural incretins and can mimic their effect
One of the lesser oxidative metabolites, 4-ene-VPA, causes hepatotoxicity in rats
N.SongX
